Neurodevelopmental

Intellectual Disability: cell-therapy evidence and registered trials

A source-first research page for the exact condition. It does not recommend a cell product, clinic or private treatment.

Registry snapshot

ClinicalTrials.gov returned 2 registered studies for the stored condition/intervention query, including 1 recruiting records, retrieved 2026-08-05T06:02:03+00:00. A registry count does not establish efficacy, approval, relevance or eligibility; inspect each study's design, product, status and inclusion criteria.

What to verify before interpreting a study or offer

  1. The exact product, cell source, processing, dose and delivery route.
  2. The indication, study phase, comparator, endpoints, status and eligibility criteria.
  3. Whether the proposed use is authorised, part of a registered trial or otherwise investigational.
  4. Provider and manufacturing authorisations, release testing, traceability and adverse-event reporting.
  5. How the proposal compares with current standard care, reviewed by an independent physician.

Sources & further reading

Registry data is a discovery aid, not evidence that a treatment works or is suitable for an individual patient.

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Get an honest assessment